Quantum Biopharma Files 6-K, Incorporates Exhibits
Ticker: QNTM · Form: 6-K · Filed: May 14, 2025 · CIK: 1771885
| Field | Detail |
|---|---|
| Company | Quantum Biopharma Ltd. (QNTM) |
| Form Type | 6-K |
| Filed Date | May 14, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: filing, registration-statement, corporate-action
TL;DR
Quantum Biopharma filed a 6-K, linking new docs to its F-3 registration. Watch for potential offerings.
AI Summary
Quantum Biopharma Ltd. filed a Form 6-K on May 14, 2025, incorporating by reference exhibits 99.1 and 99.2 into its existing Registration Statement on Form F-3 (SEC File No. 333-276264). The company, formerly known as FSD Pharma Inc. until March 27, 2019, is based in Toronto, Canada.
Why It Matters
This filing indicates that Quantum Biopharma is updating or supplementing its existing registration statement, which could be related to future offerings or ongoing reporting requirements.
Risk Assessment
Risk Level: low — This is a routine filing to incorporate exhibits into an existing registration statement, not indicating new material events or financial distress.
Key Numbers
- 001-39152 — Commission File Number (Identifies the company's filing with the SEC.)
- 333-276264 — Registration Statement File Number (Refers to the company's existing F-3 registration statement.)
Key Players & Entities
- Quantum Biopharma Ltd. (company) — Filer of the 6-K
- FSD Pharma Inc. (company) — Former name of Quantum Biopharma Ltd.
- May 14, 2025 (date) — Filing date of the 6-K
- 333-276264 (document_id) — SEC File Number for Registration Statement on Form F-3
- 001-39152 (document_id) — SEC Commission File Number
FAQ
What is the purpose of incorporating exhibits 99.1 and 99.2 into the Form F-3 registration statement?
The filing states that the exhibits are incorporated by reference into the Registrant's Registration Statement on Form F-3, suggesting they contain information relevant to the registration, such as updated disclosures or details about securities.
When did Quantum Biopharma Ltd. change its name from FSD Pharma Inc.?
The company changed its name from FSD Pharma Inc. on March 27, 2019.
What is the principal executive office address of Quantum Biopharma Ltd.?
The principal executive office is located at 55 University Avenue, Suite 1003, Toronto, Ontario M5J 2H7, Canada.
Does Quantum Biopharma Ltd. file annual reports under Form 20-F or Form 40-F?
Quantum Biopharma Ltd. indicates it files annual reports under Form 20-F.
What is the SIC code for Quantum Biopharma Ltd.?
The Standard Industrial Classification (SIC) code for Quantum Biopharma Ltd. is 2834, which corresponds to Pharmaceutical Preparations.
Filing Details
This Form 6-K (Form 6-K) was filed with the SEC on May 14, 2025 regarding Quantum Biopharma Ltd. (QNTM).